![Fred Grossman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred Grossman
President bij
COYA THERAPEUTICS, INC.
Vermogen: 13 062 $ op 31-05-2026
Profiel
Dr. Fred Grossman is a President & Chief Medical Officer at Coya Therapeutics, Inc. Dr. Grossman was previously employed as a Chief Medical Officer by Empyrean Neuroscience, Inc., a Chief Medical Officer by Mesoblast Ltd., a Chief Medical Officer by Mesoblast, Inc., a President & Chief Medical Officer by Glenmark Pharmaceuticals Ltd., a President & Chief Medical Officer by Glenmark Pharmaceuticals Inc., USA, a Head-Clinical Development & Medical Affairs by Sunovion Pharmaceuticals, Inc., and a Global Head-Medical Affairs Organization by Bristol Myers Squibb Co. He also served on the board at Reunion Neuroscience, Inc. He received his undergraduate degree from Hahnemann University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-05-2026 | 2.710 ( 0,01% ) | 13 062 $ | 31-05-2026 |
Actieve functies van Fred Grossman
| Bedrijven | Functie | Begin |
|---|---|---|
| COYA THERAPEUTICS, INC. | President | 17-07-2023 |
Eerdere bekende functies van Fred Grossman
| Bedrijven | Functie | Einde |
|---|---|---|
Empyrean Neuroscience, Inc.
 Empyrean Neuroscience, Inc. Pharmaceuticals: OtherHealth Technology Engages in genetic engineering of fungi and plants to create neuroactive therapeutics | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| MESOBLAST LIMITED | Hoofd Techniek/Wetenschap/O&O | 02-02-2022 |
| GLENMARK PHARMACEUTICALS LIMITED | President | 01-01-2019 |
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic pharmaceutical products | President | 01-08-2018 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01-10-2015 |
Opleiding van Fred Grossman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
76
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Glenmark Pharmaceuticals Ltd.
 Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic pharmaceutical products | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Empyrean Neuroscience, Inc.
Empyrean Neuroscience, Inc. Pharmaceuticals: OtherHealth Technology Engages in genetic engineering of fungi and plants to create neuroactive therapeutics | Health Technology |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
